Medical Subject Headings

Last uploaded: January 16, 2025

Id	http://purl.bioontology.org/ontology/MESH/C062127 http://purl.bioontology.org/ontology/MESH/C062127
Preferred Name	nadifloxacin
Synonyms	OPC 7251 S-NDFX 1H,5H-Benzo(ij)quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (+-)- R-NDFX OPC-7251 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1H,5H-benzo(i,j)quinolizine-2-carboxylic acid
Type	http://www.w3.org/2002/07/owl#Class

altLabel	OPC 7251 S-NDFX 1H,5H-Benzo(ij)quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (+-)- R-NDFX OPC-7251 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1H,5H-benzo(i,j)quinolizine-2-carboxylic acid See more See less
prefLabel	nadifloxacin
TH	NLM (1990) USAN (19XX) INN (19XX) USAN (1995) FDA SRS (2015)
notation	C062127
RR	124858-35-1
PA	D059005 D000900
MMR	20141102
MeSH Frequency	61
Semantic type UMLS property	http://purl.bioontology.org/ontology/STY/T121 http://purl.bioontology.org/ontology/STY/T195 http://purl.bioontology.org/ontology/STY/T109
HM	D024841 D011807
Inverse of RB	6CL9Y5YZEQ
Scope Statement	(R)-isomer does not induce chromosomal aberrations, unlike (S)-isomer; structure given in first source
MDA	19900125
SC	1
type	http://www.w3.org/2002/07/owl#Class
Mapped to	http://purl.bioontology.org/ontology/MESH/D024841 http://purl.bioontology.org/ontology/MESH/D011807
tui	T109 T195 T121
SRC	Chem Pharm Bull (Tokyo) 1989;37(8):2103
cui	C0286401 C0286400 C0069566 C0286402
isa	http://purl.bioontology.org/ontology/MESH/D059005 http://purl.bioontology.org/ontology/MESH/D000900
TERMUI	T202076 T202078 T202080 T202077 T202081 T202079 See more See less

Delete	Subject	Author	Type	Created
No notes to display